MAPT and Alzheimer disease: Unlike Aβ PET, tau PET imaging patterns are strongly correlated with cognitive function and clinical AD phenotypes (Aschenbrenner et al., 2018; Ossenkoppele et al., 2016), and tau PET abnormalities are closely aligned with 18F-FDG PET hypometabolism (Ossenkoppele et al., 2016).